While in vivo mechanisms of albumin transport and cellular uptake are complex and still not fully understood29, taken together our data suggests that nAlb that accumulates at tumor sites is macropinocytosed, primarily by tumor-associated myeloid cells, resulting in lysosomal degradation and release of a diABZI variant that activates STING. Here, STING1 is linked to neoplasm.